Mental health and substance abuse impacts 18,000 youths and 54,000 adults in Idaho. Dr. Ron Larson, Medical Director for Optum Health, joins Idaho Matters to discuss removing the stigmas attached to these disorders.
'This Is My Brave' director Erin Lorensen and writer/blogger Sivaquoi Laughlin discuss using theater to reduce the stigmas attached to mental illness with Idaho Matters on Tuesday, September 25, 2018.
'This Is My Brave' is a community performance of storytellers sharing their experiences in an effort to reduce the stigma attached to mental illness. Through song, poetry and the spoken word, performers address the sometimes uncomfortable topics surrounding mental health and we talk with one of the performers about the upcoming performance.
Southwest District Health is partnering with Lifeways to open a crisis center in Caldwell. Both organizations provide a variety of healthcare-related services, but this would provide emergency intervention for mental health and substance abuse crises.
Click 'play' to hear the audio version of this story.
A new state-sponsored substance abuse recovery center is expected to open next month in eastern Idaho.
The Post Register reports that the Center for Hope in Idaho Falls is expected to open in mid-July. It's the eighth such facility created in Idaho.
The effort to open the center began two years ago when the Idaho Association of Counties asked lawmakers to fund the facilities across the state. Along with the Center for Hope, recovery centers have been funded in Bannock, Kootenai and Nez Perce counties this year.
Three versions of a synthetic hallucinogenic drug appear bound for Idaho's list of illegal substances after the federal Drug Enforcement Administration placed them on the same list as marijuana, heroin and LSD.
The federal drug agency made the announcement on Tuesday for drugs known by their street names that include 25i, Smiles, and N-Bomb.
For substances declared by the federal government as among the most dangerous drugs, Idaho law requires the Idaho State Board of Pharmacy to control the substance after 30 days — unless state regulators find reason to object.